Market Tracker

06/27 10:10am ET
13.00
BATS BZX Real-Time Price
As of 10:10am ET
 -0.125 / -0.95%
Today’s Change
8.67
Today|||52-Week Range
14.55
+21.45%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close13.12
Today’s open13.06
Day’s range12.93 - 13.08
Volume7,485
Average volume (3 months)1,281,508
Market cap$1.4B
Dividend yield--
Data as of 10:10am ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+111.32%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio20.2
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.06+0.60%
EBSEmergent BioSolution...-0.30-0.87%
CORTCorcept Therapeutics...-0.06-0.49%
ARRYArray Biopharma Inc-0.02-0.22%
Data as of 10:10am ET, 06/27/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts